Lenvatol 4mg
Lenvatinib
Lenvatol 4mg Capsule treats thyroid cancer by blocking proteins that promote cancer cell growth. It slows disease progression and may help reduce tumor size.
- Strengths 4mg
- Form Capsules
- Packaging Size 10 Capsules
- Packaging Type Box
- Manufacturer Cipla Ltd
Description
Lenvatol 4mg Capsule is an oral cancer therapy used for the treatment of thyroid cancer. It works by blocking specific proteins that promote tumor growth and spread, slowing the progression of the disease. Lenvatol 4mg can be taken with or without food, ideally at the same time each day for maximum effectiveness. Your doctor will determine the right dosage based on your condition. Do not alter or stop taking it unless advised. Results may take weeks or months to appear, so continue the treatment as prescribed. Serious side effects may occur if taken incorrectly.
Ingredients
- Active Ingredient: Lenvatinib (4mg)
- Inactive Ingredients: Excipients as per formulation
Usage
- Indication:
- Used for the treatment of thyroid cancer.
- Dosage:
- Typically, as prescribed by the doctor, depending on cancer stage and patient response.
- Take with or without food, at the same time daily.
- Missed Dose:
- Take it as soon as remembered, unless it's almost time for the next dose.
- Do not double the dose.
Precautions
- Follow your doctor’s exact prescription to avoid severe side effects.
- May cause high blood pressure, fatigue, nausea, diarrhea, weight loss, and swelling—report any persistent issues.
- Regular blood pressure monitoring is recommended.
- Do not stop or adjust the dose without medical consultation.
- Avoid if you have severe liver or kidney disease—consult your doctor before use.
- Pregnant or breastfeeding women should avoid this medication due to potential risks to the baby.
- Avoid alcohol and grapefruit, as they may interfere with the medicine.
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.
